CDH2 and prostate carcinoma: Yu et al. found that the rs643555C > T site of CDH2 can be used as a prognostic marker for prostate cancer (PCa)9, while Gao et al. showed that CDH2 is the target for miR-194 using luciferase reporter gene analysis.